-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
At HK$8.20, Is Health and Happiness (H&H) International Holdings Limited (HKG:1112) Worth Looking At Closely?
At HK$8.20, Is Health and Happiness (H&H) International Holdings Limited (HKG:1112) Worth Looking At Closely?
Health and Happiness (H&H) International Holdings Limited (HKG:1112), might not be a large cap stock, but it saw significant share price movement during recent months on the SEHK, rising to highs of HK$13.48 and falling to the lows of HK$8.20. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Health and Happiness (H&H) International Holdings' current trading price of HK$8.20 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Health and Happiness (H&H) International Holdings's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
View our latest analysis for Health and Happiness (H&H) International Holdings
What is Health and Happiness (H&H) International Holdings worth?
According to my price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. In this instance, I've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. I find that Health and Happiness (H&H) International Holdings's ratio of 8.92x is trading slightly below its industry peers' ratio of 10.32x, which means if you buy Health and Happiness (H&H) International Holdings today, you'd be paying a decent price for it. And if you believe Health and Happiness (H&H) International Holdings should be trading in this range, then there isn't much room for the share price to grow beyond the levels of other industry peers over the long-term. Furthermore, it seems like Health and Happiness (H&H) International Holdings's share price is quite stable, which means there may be less chances to buy low in the future now that it's priced similarly to industry peers. This is because the stock is less volatile than the wider market given its low beta.
Can we expect growth from Health and Happiness (H&H) International Holdings?
SEHK:1112 Earnings and Revenue Growth May 10th 2022Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Health and Happiness (H&H) International Holdings' earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.
What this means for you:
Are you a shareholder? 1112's optimistic future growth appears to have been factored into the current share price, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the track record of its management team. Have these factors changed since the last time you looked at 1112? Will you have enough confidence to invest in the company should the price drop below the industry PE ratio?
Are you a potential investor? If you've been keeping tabs on 1112, now may not be the most advantageous time to buy, given it is trading around industry price multiples. However, the optimistic forecast is encouraging for 1112, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. To that end, you should learn about the 4 warning signs we've spotted with Health and Happiness (H&H) International Holdings (including 1 which is significant).
If you are no longer interested in Health and Happiness (H&H) International Holdings, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Health and Happiness (H&H) International Holdings Limited (HKG:1112), might not be a large cap stock, but it saw significant share price movement during recent months on the SEHK, rising to highs of HK$13.48 and falling to the lows of HK$8.20. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Health and Happiness (H&H) International Holdings' current trading price of HK$8.20 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Health and Happiness (H&H) International Holdings's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
健康幸福(H&H)国际控股有限公司(HKG:1112)可能不是一只大盘股,但它在联交所的股价在最近几个月大幅波动,升至13.48港元的高点,并跌至8.20港元的低点。一些股价波动可以让投资者有更好的机会买入股票,并有可能以更低的价格买入。一个需要回答的问题是,健康幸福(H&H)国际控股公司目前8.20港元的交易价格是否反映了小盘股的实际价值?或者,它目前被低估了,为我们提供了买入的机会?让我们来看看基于最新财务数据的健康幸福(H&H)国际控股公司的前景和价值,看看是否有任何推动价格变化的催化剂。
View our latest analysis for Health and Happiness (H&H) International Holdings
查看我们对健康幸福(H&H)国际控股公司的最新分析
What is Health and Happiness (H&H) International Holdings worth?
健康与幸福(H&H)国际控股公司价值多少?
According to my price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. In this instance, I've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. I find that Health and Happiness (H&H) International Holdings's ratio of 8.92x is trading slightly below its industry peers' ratio of 10.32x, which means if you buy Health and Happiness (H&H) International Holdings today, you'd be paying a decent price for it. And if you believe Health and Happiness (H&H) International Holdings should be trading in this range, then there isn't much room for the share price to grow beyond the levels of other industry peers over the long-term. Furthermore, it seems like Health and Happiness (H&H) International Holdings's share price is quite stable, which means there may be less chances to buy low in the future now that it's priced similarly to industry peers. This is because the stock is less volatile than the wider market given its low beta.
根据我的市盈率模型,该模型将公司的市盈率与行业平均水平进行了比较,股价似乎是稳定的。在这种情况下,考虑到没有足够的信息来可靠地预测股票的现金流,我使用了市盈率(PE)。我发现,健康幸福(H&H)国际控股公司的市盈率为8.92倍,略低于行业同行的10.32倍,这意味着如果你今天买入健康幸福(H&H)国际控股公司,你将支付一个相当不错的价格。如果你认为健康幸福(H&H)国际控股公司的股价应该在这个范围内交易,那么从长远来看,该公司股价没有太大的增长空间,没有超过其他行业同行的水平。此外,健康幸福(H&H)国际控股公司的股价似乎相当稳定,这意味着由于其定价与行业同行相似,未来可能较少有机会逢低买入。这是因为,鉴于其贝塔系数较低,该股的波动性低于大盘。
Can we expect growth from Health and Happiness (H&H) International Holdings?
我们能指望健康幸福(H&H)国际控股公司实现增长吗?
Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Health and Happiness (H&H) International Holdings' earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.
当你考虑购买一只股票时,未来前景是一个重要的方面,特别是如果你是一个寻求投资组合增长的投资者。以低廉的价格收购一家前景稳健的伟大公司永远是一笔不错的投资,所以让我们也来看看该公司的未来预期。健康与幸福(H&H)国际控股公司未来几年的收益预计将翻一番,预示着非常乐观的未来。这应该会带来更强劲的现金流,从而推动更高的股价。
What this means for you:
这对你意味着什么:
Are you a shareholder? 1112's optimistic future growth appears to have been factored into the current share price, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the track record of its management team. Have these factors changed since the last time you looked at 1112? Will you have enough confidence to invest in the company should the price drop below the industry PE ratio?
你是股东吗?1112乐观的未来增长似乎已被计入目前的股价,其股价在行业市盈率附近交易。然而,还有其他重要的因素我们今天没有考虑,比如它的管理团队的记录。自上次您关注1112以来,这些因素是否发生了变化?如果股价跌破行业市盈率,你会有足够的信心投资该公司吗?
Are you a potential investor? If you've been keeping tabs on 1112, now may not be the most advantageous time to buy, given it is trading around industry price multiples. However, the optimistic forecast is encouraging for 1112, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
你是潜在的投资者吗?如果你一直在关注1112,现在可能不是买入的最有利时机,因为它的交易价格在行业市盈率附近。然而,乐观的预测对1112来说是令人鼓舞的,这意味着为了利用下一次价格下跌,它值得更深入地研究其他因素,如其资产负债表的实力。
So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. To that end, you should learn about the 4 warning signs we've spotted with Health and Happiness (H&H) International Holdings (including 1 which is significant).
因此,如果你想更深入地研究这只股票,考虑它面临的任何风险是至关重要的。为此,您应该了解4个警示标志我们发现了健康幸福(H&H)国际控股公司(包括1家意义重大的公司)。
If you are no longer interested in Health and Happiness (H&H) International Holdings, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
如果您对健康幸福(H&H)国际控股不再感兴趣,您可以使用我们的免费平台查看我们的其他50多只具有高增长潜力的股票。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧